Three weeks ago, Nextbigfuture covered the cancer treatment breakthrough made by researchers at the University of Cardiff. Now SciShow has a video that explains how this discovery was made and why it is so promising. The researchers took a range of killer t-cells from the body and tested them against cancer. One of the killer …
Reseachers have identified a biomarker for early detection of liver cancer. With current tests like biopsies, cancer in the liver is often detected in advanced stages, which can limit treatment options and lower overall survival rates. The discovery could have wide-ranging impacts, including more effective diagnosis and precision treatment, and less risk to patients. “This …
The US Department of Energy (DOE) will provide USD10 million over three years to advance particle accelerator technology for medical, security, energy, and industrial applications. The DOE Accelerator Stewardship program has already helped reduce the cost and improve the quality of cancer therapy, advance non-chemical methods of destroying pathogens and toxic chemicals, and enhance security …
Researchers at Cardiff University have discovered a new type of killer T-cell that offers hope of a “one-size-fits-all” cancer therapy. T-cells with the new TCR were shown, in the lab, to kill lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney and cervical cancer cells, while ignoring healthy cells. The researchers injected T-cells able to …
The brain has barriers to protect itself from bacteria and other pathogens but if infections and diseases get past those barriers then the immune system is also kept out. Yale researchers have found a way to get immune system rescuers through the brain’s protective drainage system. Tiny vessels are form shortly after birth, spurred in …
Telomerase is present in 90% of human cancer cells and contributes significantly to proliferative abilities and immortality of cancer cells. MAIA Biotechnology is developing a Telomerase-Mediated Approach to Fighting Cancer. Telomerase is either absent or shows low activity in normal cells. THIO(6-thio-dG) is recognized by telomerase and incorporated into telomeres. Once incorporated, it compromises telomere …
AI, Genome Sequencing and New Sensors Creates Pre-Cancer Management
It’s a question that everybody’s asking, since everyone knows someone who has been diagnosed or is currently dealing with some form of cancer: just how close are we to curing the disease? We’re at a point where a cancer diagnosis is scary, but manageable in many cases. After getting a breast cancer diagnosis, for example, …
A new cancer drugs work by targeting tumors by their genetic make-up instead of where originate in the body. On November 26, 2018, the Food and Drug Administration granted accelerated approval to larotrectinib (VITRAKVI, Loxo Oncology Inc. and Bayer) for adult and pediatric patients with solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) …
A combination treatment of intensive chemotherapy and radiation therapy, as well as the blood pressure drug losartan enables many previously inoperable pancreatic cancer tumors to be removed. The work was done at Massachusetts General Hospital and will expand to more institutions in an expanded study. Using the combo therapy allowed 34 of the 49 participants …
Mayo Clinic Dr. Truty and his colleagues start treating pancreatic cancer with new chemotherapy drugs before surgery, rather than afterward and are able to increase survival rates by five times.